BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis.
BioSkryb Genomics has raised $10.0M in total funding. The most recent round was Convertible Note. The last funding was announced in March 2022.
BioSkryb Genomics's investors include Anzu Partners, Wilson Sonsini Goodrich & Rosati.
BioSkryb Genomics is headquartered in Durham, United States.
BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis.
BioSkryb Genomics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioSkryb Genomics — Funding & Investors." VCBacked, March 3, 2022, https://www.vcbacked.co/company/bioskryb-genomics. Accessed September 30, 2026.
VCBacked. (2022). BioSkryb Genomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/bioskryb-genomics
{{cite web |title=BioSkryb Genomics — Funding & Investors |url=https://www.vcbacked.co/company/bioskryb-genomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated